Printer Friendly

Browse Metastasis topic

Articles

1-300 out of 500 article(s) nextnext page
Title Author Type Date Words
United States : Advaxis Submits Conditional Marketing Authorization Application For Axalimogene Filolisbac For The Second-Line Treatment Of Metastatic Cervical Cancer In European Union. Feb 19, 2018 500
Results of Phase II Trial of Durvalumab in Recurrent or Metastatic Head and Neck Cancer with Low or Negative Expression of PD-L1 Protein Presented at 2018 Multidisciplinary Head and Neck Cancers Symposium. Feb 16, 2018 308
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 304
The Janssen Pharmaceutical Companies wins the US FDA's approval for ERLEADA for non-metastatic castration-resistant prostate cancer. Feb 15, 2018 300
Janssen Files MAA for Apalutamide for Treatment of High-Risk Non-Metastatic CRPC in Europe. Feb 14, 2018 282
United States : Apalutamide helps delay spread of several prostate cancers in phase 3 clinical trial. Feb 13, 2018 306
Combatcancer: Rational combination therapies for metastatic cancer. Feb 12, 2018 372
Xtandi Plus ADT Reduces Risk of Metastasis, Death, PSA Progression in Men with CRPC Compared to ADT Alone. Feb 9, 2018 420
United States : ZYTIGA (abiraterone acetate) Plus Prednisone Approved for Treatment of Earlier Form of Metastatic Prostate Cancer. Feb 9, 2018 543
United States : ERLEADA (apalutamide), a Next-Generation Androgen Receptor Inhibitor, Lowered Risk of Metastasis or Death in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Feb 9, 2018 297
Japan : Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. Feb 8, 2018 352
Germany : Bayer to showcase latest prostate cancer research at ASCO GU 2018 Cancer Symposium. Feb 8, 2018 479
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 215
ANGLE plc and Abbott Laboratories to collaborate on metastatic breast cancer study. Feb 6, 2018 211
Astellas Pharma, Pfizer announce results from Phase 3 PROSPER trial. Feb 5, 2018 164
USPTO Grants Skin Biology Patent for Non-toxic Skin Cancer Therapy with Copper Peptides. Feb 2, 2018 152
FDA GRANTS FAST TRACK DESIGNATION TO ANTI-HER2. Feb 1, 2018 878
Colorectal cancer in South Africa: An assessment of disease presentation, treatment pathways and 5-year survival. Brand, M.; Gaylard, P.; Ramos, J. Report Feb 1, 2018 3512
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 131
Alligator Bioscience selects Theradex Oncology as CRO for planned phase I study of ATOR-1015. Jan 29, 2018 127
FDA Grants Synthon Fast Track Designation for Anti-HER2 ADC for Pre-treated HER2-positive Metastatic Breast Cancer. Jan 29, 2018 208
Sustained Ventricular Tachycardia Secondary to Cardiac Metastasis of Lung Cancer. Li, Ying-Ying; Wang, Hua; Cui, Ya-Dong; Liu, Hang-Yu; Yang, Jie-Fu Jan 27, 2018 1192
Clinical Data from Taiho Oncology and Servier Study of Lonsurf (trifluridine and tipiracil) in Metastatic Colorectal Cancer Presented at ASCO 2018 Gastrointestinal Cancers Symposium. Jan 24, 2018 436
Amgen and Allergan's MVASI (Biosimilar Bevacizumab) Approved by European Commission for Treatment of Certain Cancers. Jan 24, 2018 362
United States : European Commission Approves Bristol-Myers Squibbs Yervoy (ipilimumab) for Treatment of Pediatric Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Jan 23, 2018 288
Exelixis Presents Phase 1b Results for Cobimetinib plus Atezolizumab in Metastatic Colorectal Cancer at the 2018 ASCO Gastrointestinal Cancers Symposium. Jan 23, 2018 443
Opdivo plus Yervoy Shows 55% ORR at 13.4 Months in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 328
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrates Clinical Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer. Jan 22, 2018 380
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 260
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 261
Bavarian Nordic initiates clinical trial with Brachyury in cancer metastasis. Jan 19, 2018 256
Amgen and Allergan's Mvasi for certain cancers approved in Europe. Jan 18, 2018 114
US FDA Approves Lynparza (olaparib) for Germline BRCA-Mutated Metastatic Breast Cancer. Jan 17, 2018 492
CytRx begins dosing in clinical trial for metastatic pancreatic cancer candidate. Jan 17, 2018 141
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 207
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
Canada,United States : Mercks KEYTRUDA(R) (pembrolizumab) Significantly Improved Overall Survival and Progression-Free Survival as First-Line Treatment in Combination with Pemetrexed and Platinum Chemotherapy for Patients with Metastatic Nonsquamous Non-S. Jan 17, 2018 209
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 347
AstraZeneca wins US FDA expanded approval for Lynparza (olaparib tablets) to treat patients with germline susceptibility gene (BRCA) (HER2)-negative metastatic breast cancer. Jan 15, 2018 343
AstraZeneca and Merck announces FDA approval of Lynparza for metastatic breast cancer. Jan 15, 2018 431
Canada,United States : U.S. FDA Approves LYNPARZA (olaparib) in Germline BRCA-Mutated Metastatic Breast Cancer. Jan 14, 2018 700
Radiotherapy for Gastrointestinal Stromal Tumors. Ozkan, Emine Jan 13, 2018 6095
Eisai and Merck & Co. Receive Breakthrough Therapy Designation from U.S. FDA for LENVIMA and KEYTRUDA. Jan 9, 2018 1432
Bad cholesterol helps cancer spread. Jan 3, 2018 226
New Biomarker Predicts Metastatic Prostate Cancers. Jan 1, 2018 220
Personalized medicine offers new hope to breast cancer patients. Jan 1, 2018 2236
Plasma hepatic enzymes as biopredictors of type, metastasis, and prognostication of hematological malignancies. Akinlolu, Abdulazeez; Salau, Bamidele; Odewabi, Adesina; Biliaminu, Sikiru; Abdulazeez, Ishola Jan 1, 2018 2489
Odonate Therapeutics Begins Phase 3 Study of Tesetaxel in Patients with Locally Advanced or Metastatic Breast Cancer. Dec 29, 2017 232
Janssen NDA for Apalutamide as Treatment for Non-Metastatic CRPC Garners Priority Review from US FDA. Dec 26, 2017 284
FDA approves Nanobiotix's first Immuno-Oncology trial. Dec 26, 2017 1718
Bad cholesterol can help cancer spread, scientists warn. Dec 23, 2017 207
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 282
Janssen Biotech passes the US FDA's priority review designation for the New Drug Application (NDA) for apalutamide for prostate cancer. Dec 22, 2017 278
United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) as Adjuvant Therapy in Patients with Completely Resected Melanoma with Lymph Node Involvement or Metastatic Disease. Dec 21, 2017 303
CHMP Recommends Approval of Yervoy (ipilimumab) for the Treatment of Patients 12 Years and Older with Unresectable or Metastatic Melanoma. Dec 19, 2017 351
Eisai: Updated Analysis of Phase Ib/II Study of Eribulin and Pembrolizumab Combination Regimen. Dec 8, 2017 1455
Ibrance (palbociclib) plus Letrozole Improves Progression-Free Survival in ER+, HER2- Metastatic Breast Cancer. Dec 7, 2017 372
Preclinical Data Show Agilvax AX09 Immunotherapy Reduces Tumor Growth and Pulmonary Metastases in Triple Negative Breast Cancer. Dec 7, 2017 252
Fitbit Aids In Understanding Cancer Surgery Recovery Better. Dec 6, 2017 534
Metastatic Melanoma - Pipeline Review, H2 2015 Now Available at iData Insights. Dec 1, 2017 1841
Germany : Phase III trial of radium-223 dichloride in combination with abiraterone acetate and prednisone/prednisolone for patients with metastatic castration-resistant prostate cancer unblinded early. Dec 1, 2017 346
Systemic Therapy after Radiotherapy Significantly Reduces the Risk of Mortality of Patients with 1-3 Brain Metastases: A Retrospective Study of 250 Patients. Li, Bo; Dai, Zhao-Xia; Chen, Yi-Dong; Liu, Yan-Wei; Liu, Shuai; Gu, Xue-Nan; Qiu, Xiao-Guang Dec 1, 2017 4164
Electrochemotherapy treatment of oral extramedullary plasmacytoma of the tongue: a retrospective study of three dogs/Eletroquimioterapia no tratamento de plasmocitoma extramedular oral na lingua: estudo retrospectivo de tres caes. Cunha, Rubia Monteiro de Castro; Lavalle, Gleidice Eunice; Caires, Carla Emanuela Tertuliano; de Ara Dec 1, 2017 2038
Gene Expression, and Fatigue in Puerto Rican Men during Radiotherapy for Prostate Cancer: an Exploratory Study. Gonzalez, Velda J.; Saligan, Leorey N.; Fridley, Brooke L.; Ortiz-Zuazaga, Humberto; Aaronson, Laure Dec 1, 2017 6201
Myeloid sarcoma of the thyroid. Goldenberg, Dana; Joshi, Monika; Malysz, Jozef; Claxton, David; Cottrill, Elizabeth E. Report Dec 1, 2017 867
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 236
AstraZeneca reports acceptance by EMA of Tagrisso submission for 1st-line NSCLC. Nov 28, 2017 237
A key to stopping cancer in its tracks. Nov 19, 2017 374
Severe Pneumonitis after Nivolumab Treatment Accompanied by Acute Pulmonary Embolism in a Patient with Lung Adenocarcinoma. Liao, Ji-Ping; Nie, Li-Gong; Que, Cheng-Li; Mu, Xiang-Dong Nov 18, 2017 1267
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 260
Amgen and Allergan given positive opinion by CHMP for ABP 215, a biosimilar to Avastin. Nov 16, 2017 256
Germany : Novartis reports positive results from Phase III trial of Kisqali (ribociclib) combination therapy in premenopausal women with HR+/HER2- advanced or metastatic breast cancer. Nov 9, 2017 328
Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention. Li, Tian-Ran; Yu, Ming-Hui; Huang, Xiao-Bin; Yang, Zhi-Jie; Lu, Guang-Ming; Li, Yan-Jun Nov 5, 2017 5584
Impact of distant and regional metastasis of non-small-cell lung cancer on endotoxicosis development. Belskaya, Lyudmila V.; Kosenok, Viktor K.; Sarf, Elena A.; Zhuchkov, Sergey A. Nov 1, 2017 5176
Case: Secondary polycythemia due to pazopanib in patients with metastatic renal cell carcinoma. Bukhari, Nedal Report Nov 1, 2017 1532
MiR-34-a acts as a suppressor in neuroblastoma progression by targeting CD44. Oct 31, 2017 4267
De novo descending aorta thrombus in a patient with metastatic colorectal cancer: A case report. Oct 31, 2017 1434
Five-year Survival of Newly Diagnosed Stage Four Breast Cancer Has improved. Oct 30, 2017 389
Eagle Pharmaceuticals Receives Tentative FDA Approval for Pemfexy Ready-to-Dilute. Oct 30, 2017 299
A Tuberous Sclerosis Family with TSC1 (c.1030-1G>A) Mutation Found through a Female Presenting as Multiple Ground Glass Nodules in Chest Computed Tomography Incidentally. Zhao, Ting-Ting; Wang, Yong-Sheng; Li, Yan; Ma, Miao; Li, Ai-Mei; Cai, Hou-Rong; Fan, Xiang-Shan; Me Report Oct 20, 2017 1482
OncoSec Releases Data from Recently Completed Studies of ImmunoPulse IL-12 Monotherapy or in Combination with Pembrolizumab in Metastatic Melanoma Patients. Oct 20, 2017 428
Pfizer Study of ALK-Inhibitor Lorlatinib Shows Positive Results Against NSCLC Tumors and Brain Metastases. Oct 18, 2017 409
Halozyme Initiates Clinical Trial Of PEGPH20 With Anti-PDL1 Immunotherapy In Cholangiocarcinoma And Gallbladder Cancer Patients. Oct 16, 2017 900
Aprea Therapeutics Announces First Patients Enrolled in Phase Ib/II Clinical Study of APR-246 for the Treatment of Esophageal Cancer. Clinical report Oct 16, 2017 665
Protein Biomarker Heterogeneity Observed in Metastatic Breast Cancer Patients. Clinical report Oct 16, 2017 266
US FDA receives new drug application from Janssen Biotech for Apalutamide. Oct 13, 2017 166
Liquid Biopsy Test Identifies Androgen Receptor Protein Expression in Circulating Tumor Cells in Women with Metastatic Breast Cancer. Oct 13, 2017 602
United States : Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 394
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 244
Janssen Biotech submits NDA with the US FDA for apalutamide for non-metastatic castration-resistant prostate cancer. Oct 12, 2017 240
FDA Grants Priority Review for Potential New Indication for Lilly's Verzenio(TM) (abemaciclib) as Initial Treatment of Advanced Breast Cancer. Oct 12, 2017 3098
Janssen Submits NDA to US FDA for Apalutamide for Treatment of Non-Metastatic Castration-Resistant Prostate Cancer. Oct 12, 2017 197
Oncolytics Biotech[R] to Present at the 2017 BIO Investor Forum. Oct 11, 2017 949
Janssen Submits New Drug Application to U.S. FDA for Apalutamide (ARN-509) to Treat Men with Non-Metastatic Castration-Resistant Prostate Cancer. Oct 11, 2017 1322
Theresa's Research Foundation Hosts 4th Annual Metastatic Breast Cancer Conference. Conference news Oct 11, 2017 496
OncoSec Begins Enrollment in Clinical Trial of ImmunoPulse IL-12 in Combination with Keytruda (pembrolizumab) in Patients with Unresectable Metastatic Melanoma. Oct 11, 2017 349
Astellas and Seattle Genetics Initiate Pivotal Trial of Enfortumab Vedotin for Patients with Locally Advanced or Metastatic Urothelial Cancer. Oct 10, 2017 1310
OncoSec Initiates Registration Directed Clinical Trial, KEYNOTE-695, of ImmunoPulse IL-12 in Combination with Merck's KEYTRUDA (pembrolizumab). Oct 10, 2017 1321
Newly Published Data Expands Clinical Utility of Breast Cancer Index(SM) to Include Early-Stage, ER+ Patients with Node Positive Disease. Oct 10, 2017 1047
Q BioMed Announces Launch of PainFreeCancer.com Website in Support of Non-Opioid Cancer Pain Drug. Oct 5, 2017 1131
Strata Oncology, Inc. Announces Partnership with UCSF to Launch Stratify Prostate(TM) Initiative to Expand Access to Precision Medicine Clinical Trials for 10,000 Men with Metastatic Prostate Cancer. Oct 3, 2017 686
Susan G. Komen Launches Its First Crowdfunding Initiative To Support Metastatic Breast Cancer Research. Oct 3, 2017 1003
Can "Labyrinth" Chip Help Monitor Aggressive Cancer Stem Cells?. Oct 2, 2017 749
Salinomycin enhances doxorubicin sensitivity through reversing the epithelial-mesenchymal transition of cholangiocarcinoma cells by regulating ARK5. Yu, Z.; Cheng, H.; Zhu, H.; Cao, M.; Lu, C.; Bao, S.; Pan, Y.; Li, Y. Oct 1, 2017 3818
Chemo causes disease to spread to lungs. Oct 1, 2017 322
Serous Tubal Intraepithelial Carcinoma or Not? Metastases to Fallopian Tube Mucosa Can Masquerade as In Situ Lesions. Singh, Reena; Cho, Kathleen R. Report Oct 1, 2017 2171
Eli Lilly and Company awarded US FDA approval for Verzenio for the treatment of advanced or metastatic breast cancer. Sep 29, 2017 334
FDA approves new treatment for certain advanced or metastatic breast cancers. Sep 28, 2017 745
OncoSec Presents Clinical Overview of Comprehensive Immune Monitoring Data Demonstrating Conversion of "Cold" Tumors to "Hot" Tumors with ImmunoPulse IL-12 and Pembrolizumab Combination Therapy. Sep 27, 2017 1269
Radiation-immunotherapy combination can slow tumor growth for some patients with metastatic late-stage cancer. Sep 24, 2017 1894
Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients. Sep 24, 2017 1909
Germany : European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 22, 2017 713
European Commission Approves Bavencio (avelumab) for Metastatic Merkel Cell Carcinoma. Sep 21, 2017 4362
Merck KGaA & Pfizer Inc partnership win EC's marketing authorisation for BAVENCIO for metastatic merkel cell carcinoma. Sep 21, 2017 317
Oncolytics Biotech[R] Announces Successful End-of-Phase 2 Meeting with FDA for REOLYSIN[R] in Metastatic Breast Cancer. Sep 18, 2017 917
United States : Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer. Sep 16, 2017 355
Bavarian Nordic to discontinue Phase 3 Study of PROSTVAC in metastatic prostate cancer. Sep 15, 2017 190
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 320
Bavarian Nordic to discontinue Phase 3 Study of PROSTVAC in metastatic prostate cancer. Sep 15, 2017 186
Janssen submits supplemental NDA to US FDA for ZYTIGA for metastatic prostate cancer based on data from LATITUDE trial. Sep 15, 2017 316
United States : FDA Approves Amgen And Allergan's MVASI (bevacizumab-awwb) For The Treatment Of Five Types Of Cancer. Sep 15, 2017 390
United States : Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Sep 15, 2017 475
Pfizer and Astellas Announce Positive Top-Line Results from Phase 3 PROSPER Trial of XTANDI (enzalutamide) in Patients with Non-Metastatic Castration-Resistant Prostate Cancer. Sep 14, 2017 2884
Novartis teams up with actress, producer and activist Eva Longoria to launch Kiss This 4 MBC(TM) to generate research funding and support for the metastatic breast cancer community. Sep 14, 2017 1639
Avelas Biosciences' AVB-620 Shows Sensitive In Vivo Visualization of Breast Cancer in Journal Publication. Sep 14, 2017 496
Janssen Submits Supplemental New Drug Application to U.S. FDA for ZYTIGA (abiraterone acetate) to Treat Men with Earlier Stages of Metastatic Prostate Cancer. Sep 14, 2017 2828
Bristol-Myers Squibb Touts Positive Study Data for Opdivo, Yervoy Combination in Advanced or Metastatic Renal Cell Carcinom. Sep 12, 2017 384
Data from Pfizer Study of Trastuzumab Biosimilar Demonstrates Equivalence in ORR for Patients with HER2-positive Metastatic Breast Cancer. Clinical report Sep 12, 2017 319
Daiichi Sankyo Presents New Data for DS-8201 in Multiple HER2-Expressing Solid Tumors at European Society for Medical Oncology (ESMO) 2017 Congress. Sep 11, 2017 1393
Oncolytics Biotech[R] Announces the Presentation of REOLYSIN[R] Clinical Data at ESMO 2017 Congress. Sep 11, 2017 1176
Daiichi Sankyo Presents New Data for DS-8201 in Multiple HER2-Expressing Solid Tumors at European Society for Medical Oncology (ESMO) 2017 Congress. Sep 11, 2017 1486
United States : Lilly Builds Upon Body of Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer. Clinical report Sep 11, 2017 486
Lilly Builds Upon Body of Clinical Evidence for CYRAMZA (ramucirumab) with Phase 3 RANGE Data Demonstrating Superior Progression-Free Survival in Advanced or Metastatic Urothelial Cancer. Clinical report Sep 10, 2017 5207
Novartis Phase III study demonstrates adjuvant Tafinlar + Mekinist reduced the risk of disease recurrence by 53% in patients with resected BRAF V600 mutation-positive melanoma. Sep 10, 2017 3804
Belgium : New Data Presented at ESMO 2017 Shows That Abiraterone Acetate Plus Prednisone Provides Benefits in Patient Reported Outcomes in Both Metastatic Hormone-Sensitive and Castration-Resistant Prostate Cancer. Sep 10, 2017 163
Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies. Sep 9, 2017 1136
Phosplatin Therapeutics Announces Collaboration with Pfizer and Merck KGaA, Darmstadt, Germany to Evaluate Combination of PT-112 and Avelumab in Phase I / II Studies. Sep 9, 2017 1125
United States : CheckMate -214 Study Evaluating Opdivo in Combination with Yervoy Stopped Early for Demonstrating Overall Survival Benefit in Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Sep 8, 2017 200
Liquid Biopsy Tumor Heterogeneity Test Predicts Resistance to Targeted Therapy in Metastatic Prostate Cancer Patients. Sep 6, 2017 1050
Thermal Ablation in the Management of Adrenal Metastasis Originating from Non-small Cell Lung Cancer: A 5-year Single-center Experience. Botsa, Evanthia; Thanou, Ioanna; Papatheodoropoulou, Aspasia; Thanos, Loukas Report Sep 1, 2017 3228
Israel : Life-Prolonging Treatment for Metastatic Non-Small Cell Lung Cancer Approved for Clinical Trials. Sep 1, 2017 422
Ben Stiller Wants Men to Test for Prostate Cancer. Vanzile, Jon Sep 1, 2017 2748
Aspirin Fights Cancer. Brief article Sep 1, 2017 279
Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS)/Asociacion de Particion Hepatica y Ligadura Portal para Hepatectomia por Etapas (ALPPS). Manterota, Carlos; Otzen, Tamara Sep 1, 2017 5312
Terapia con [[sup.177]Lu--Dota0--[Tyr.sup.3]]-Octreotate ([sup.177]Lu-Dotatate) en pacientes con tumores avanzados de origen neuroendocrino: experiencia inicial y resultados preliminares. Marin-Oyaga, Victor; Gutierrez-Villamil, Claudia; Mejia-Lopez, Arturo; Valenzuela-Rincon, Alex; Sanc Sep 1, 2017 3844
Clinical and histopathological features of breast cancer in Jordan: Experience from a tertiary care hospital. Aug 31, 2017 4888
Role of surgery in brain metastases. Aug 31, 2017 1315
Eisai to Present New Clinical Data in Variety of Advanced Cancers at the ESMO 2017 Congress. Aug 31, 2017 4315
Castle Biosciences Study of Melanoma Test Demonstrates Improved Clinical Risk Assessment. Clinical report Aug 30, 2017 257
FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo's DS-8201 for HER2-Positive Metastatic Breast Cancer. Aug 29, 2017 1202
Daiichi Sankyo Initiates Pivotal Phase 2 Study of DS-8201 in Patients with HER2-Positive Metastatic Breast Cancer. Aug 29, 2017 1234
Lenvatinib Significantly Improved Overall Survival in Older Patients with Locally Recurrent or Metastatic, Progressive, Radioactive Iodine-Refractory Differentiated Thyroid Cancer According to Results of Subanalysis of Phase 3 SELECT Trial. Aug 28, 2017 3877
Switzerland : Novartis Kisqali (ribociclib) receives EU approval as first-line treatment for HR+/HER2- locally advanced or metastatic breast cancer in combination with any aromatase inhibitor. Aug 28, 2017 358
Unusual case of angiosarcoma of liver presenting with pulmonary metastasis in a young girl. Daspin, D.; Aby, Tom; Sivaraman, Ramalingam; Francis, G. Case study Aug 28, 2017 1210
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 235
The Alliance Foundation Trials launches PATINA trial for metastatic breast cancer. Aug 24, 2017 231
United States : Bristol-Myers Squibb Announces Topline Results from CheckMate -214, a Phase 3 Study of Opdivo in Combination with Yervoy in Intermediate and Poor-Risk Patients with Previously Untreated Advanced or Metastatic Renal Cell Carcinoma. Aug 16, 2017 324
Comparison of who and recist response criteria in locally advanced breast cancer--a descriptive study. Sundararaju, Vishnu Kumar Report Aug 14, 2017 2717
Madison Vaccines Doses First Patient in Trial of MVI-816 Plus Keytruda for Metastatic, Treatment-Resistant Prostate Cancer. Aug 4, 2017 308
New drug 'cuts cancer tumours by up to half'. Aug 3, 2017 170
United States : Bristol-Myers Squibb Receives FDA Approval for Opdivo (nivolumab) in MSI-H or dMMR Metastatic Colorectal Cancer That Has Progressed Following Treatment with a Fluoropyrimidine, Oxaliplatin, and Irinotecan. Aug 2, 2017 475
The molecular basis of prostate cancer and targeting therapies. Jurasunas, Serge Report Aug 1, 2017 7994
Update on Immunohistochemical Analysis in Breast Lesions. Peng, Yan; Butt, Yasmeen M.; Chen, Beiyun; Zhang, Xinmin; Tang, Ping Report Aug 1, 2017 10899
Application of Immunohistochemistry in Undifferentiated Neoplasms: A Practical Approach. Kandukuri, Shivani R.; Lin, Fan; MD; Gui, Lizhen; Gong, Yun; Fan, Fang; Chen, Longwen; Cai, Guoping; Aug 1, 2017 11483
Immune therapy durable in melanoma brain metastases. Oakes, Kari Clinical report Aug 1, 2017 773
Ocular metastasis as initial presentation in breast cancer. Maliepaard, M.; Mesham, M.; Aleksic, Z.; Scholtz, R.; Edge, J. Clinical report Aug 1, 2017 1572
Radiation therapy--an effective tool for analgesia in metastatic bone disease in breast cancer. Negi, Preety; Kingsley, Pamela Alice; Sachdeva, Jaineet; Srivastava, Himanshu Report Jul 31, 2017 2888
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 277
Astrazeneca's Phase III FLAURA trial shows strong result for Tagrisso in lung cancer. Jul 28, 2017 273
Mechanism of metastasis is discovered in pancreatic cancer. Jul 27, 2017 479
Prognostic Analysis of 102 Patients with Synchronous Colorectal Cancer and Liver Metastases Treated with Simultaneous Resection. Zhang, Ye-Fan; Mao, Rui; Chen, Xiao; Zhao, Jian-Jun; Bi, Xin-Yu; Li, Zhi-Yu; Zhou, Jian-Guo; Zhao, H Clinical report Jul 27, 2017 2435
Using Ultrasonography to Evaluate the Relationship between Capsular Invasion or Extracapsular Extension and Lymph Node Metastasis in Papillary Thyroid Carcinomas. Jiao, Wei-Ping; Zhang, Lei Clinical report Jul 27, 2017 2816
Neon Therapeutics, Apexigen to Collaborate in Clinical Trial for Metastatic Melanoma Treatment. Jul 26, 2017 289
US FDA Approves Bristol-Myers Squibb's Yervoy for Treatment of Adolescents with Unresectable or Metastatic Melanoma. Jul 25, 2017 470
Germany,United States : EMAs CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. Jul 22, 2017 592
EMA's CHMP Issues Positive Opinion for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma. Jul 21, 2017 4050
Apexigen, Inc. Announces First Patient Dosed in Phase 1b/2 Clinical Trial of APX005M in Combination with Opdivo (nivolumab) in Advanced Solid Tumors. Jul 17, 2017 805
FDA Grants Priority Review for Lilly's Abemaciclib in Advanced Breast Cancer. Jul 11, 2017 441
PDS biotechnology and Merck Subsidiary to Collaborate to Evaluate Versamune PDS0101 and Keytruda (pembrolizumab) Combination for Metastatic Head and Neck Cancer. Jul 11, 2017 266
FDA Grants Priority Review for Lilly's Abemaciclib for the Treatment of Advanced Breast Cancer. Jul 10, 2017 1565
PDS Biotechnology Corp. Announces Clinical Collaboration with Merck to Evaluate Combination of Versamune PDS0101 and KEYTRUDA (pembrolizumab) for Metastatic Head and Neck Cancer. Jul 10, 2017 657
Puma biotechnology Trial of Neratinib in Metastatic Breast Cancer Completes Targeted Enrollment. Jul 7, 2017 275
CTC4BMP: Circulating tumor cells for tailoring BMP targeted therapies. Jul 7, 2017 234
Future Cancer Treatment Could Stop Disease From Spreading. Jul 3, 2017 574
New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. Jul 3, 2017 2390
New Analysis Reveals First-Line Treatment Data on SIR-Spheres Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer. Jul 3, 2017 2396
Two cancers in one: breast carcinoma with underlying melanoma. Douville, Nicholas A.; Sakach, Elizabeth A.; Wiewiorowski, Elizabeth A.; Herlihy, William; Pippen, J Clinical report Jul 1, 2017 1772
Malignant thymoma with metastasis associated with paraneoplastic myasthenia gravis. Jazi, Hourossadat Hashemi; Harmon, David M.; Tran, Tuan; Denham, Claude Clinical report Jul 1, 2017 1546
Metastatic calcinosis cutis in end-stage renal disease. Jaeger, Victoria A.; Newman, Megan G.; Mirkes, and Curtis R. Clinical report Jul 1, 2017 1180
Calcinosis cutis and renal disease: an evolving story. Fenves, Andrew Z.; Kroshinsky, Daniela Jul 1, 2017 1423
Immediate-completion lymph node dissection in metastatic melanoma. Moon, Mary Ann Jul 1, 2017 589
Survival rates rise for younger women with de novo MBC. Osterweil, Neil Jul 1, 2017 546
Is sentinel lymph node mapping associated with acceptable performance characteristics for the detection of nodal metastases in women with endometrial cancer? Wright, Jason D. Jul 1, 2017 805
Feminizing adrenocortical carcinoma without gynecomastia. Chentli, Farida; Chabour, Fadila; Bouchibane, Djafer; Nouar, Nouria Case study Jul 1, 2017 1320
Metastatic mammary carcinoma in a cow/Carcinoma metastatico mamario em uma vaca. Piva, Manoela Marchezan; Schwertz, Claiton Ismael; Henker, Luan Cleber; Millan, Yolanda; de las Mula Jul 1, 2017 2143
Renal salt wasting syndrome in a patient receiving cisplatin chemotherapy for metastatic testicular cancer: a case report. Anderson, Christine; Linington, Ashley Clinical report Jul 1, 2017 3118
Boston Biomedical Presents Data for Investigational Cancer Stemness Inhibitor Napabucasin in Metastatic Colorectal and Pancreatic Cancer at ESMO GI 2017. Jun 30, 2017 1863
Effectiveness and safety of percutaneous vertebroplasty in the treatment of spinal metastatic tumor. Jun 30, 2017 3036
Predictive value of stathmin-1 and osteopontin expression for taxan resistance in metastatic castrate-resistant prostate cancer. Report Jun 30, 2017 3527
FDA Approves Vectibix (Panitumumab) For Use In Wild-Type RAS Metastatic Colorectal Cancer. Jun 29, 2017 3751
Novartis combination targeted therapy Tafinlar + Mekinist receives FDA approval for BRAF V600E mutant metastatic non-small cell lung cancer (NSCLC). Jun 22, 2017 3230
IsoRay Announces Study Published in The International Journal of Radiation Oncology, Biology, Physics entitled, "Clinical Outcomes of Large Brain Metastases Treated with Neurosurgical Resection and Intraoperative Cesium-131 Brachytherapy: Results of a Prospective Trial". Jun 20, 2017 889
FDA Accepts Amgen's Supplemental Biologics License Application To Expand Indication For XGEVA (denosumab) To Include Multiple Myeloma Patients. Jun 19, 2017 3477
BioPact's MGMR Drug Delivery Technology Succeeds In Mitigating Side Effects Of Doxorubicin While Retaining Anti-Cancer Efficacy In Lymphoma And Metastasis Mouse Models. Report Jun 14, 2017 460
Exelixis Starts Phase 1b Trial of Cabozantinib, Atezolizumab Combination in Locally Advanced or Metastatic Solid Tumors. Jun 14, 2017 568
Cellth Systems And University Of Maryland Enter License Agreement To Advance New Circulating-Tumor-Cell-Analysis Technology. Jun 13, 2017 679
United States : Q BioMed Announces Attendance at Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting. Jun 10, 2017 293
United States : Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 10, 2017 337
United States : Celldex Presents Promising Overall Survival Data from Phase 2 Study of Single-agent Glembatumumab Vedotin in Patients with Checkpoint-Refractory Metastatic Melanoma. Clinical report Jun 10, 2017 846
Astellas and Pfizer Announce Amendment to Clinical Research Protocol for Phase 3 PROSPER Trial of enzalutamide in Patients with Non-metastatic Castration-Resistant Prostate Cancer. Clinical report Jun 9, 2017 2325
OncoSec wins US FDA's orphan drug designation for tavokinogene telsaplasmid to treat unresectable metastatic melanoma. Jun 9, 2017 253
New Data From Biotheranostics, Inc. Further Demonstrate the Value of CancerTYPE ID to Help Identify Metastatic Cancers with an Unknown or Unclear Tumor Type Diagnosis. Jun 8, 2017 724
OncoSec Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Unresectable Metastatic Melanoma. Jun 8, 2017 661
Q BioMed Inc Announces Commercialization of Non-Narcotic Metastatic Cancer Pain Drug. Jun 7, 2017 1250
Novartis partners with Bristol-Myers Squibb to investigate Mekinist in combination with Opdivo and Opdivo + Yervoy regimen for treating metastatic colorectal cancer. Jun 6, 2017 310
Novartis partners with Bristol-Myers Squibb to investigate Mekinist in combination with Opdivo and Opdivo + Yervoy regimen for treating metastatic colorectal cancer. Jun 6, 2017 306
Novartis and Bristol-Myers Squibb team up in metastatic colorectal cancer clinical trial. Jun 6, 2017 230
Novartis and Bristol-Myers Squibb team up in metastatic colorectal cancer clinical trial. Jun 6, 2017 226
Merck Releases Results on Keytruda Studies in Metastatic Urothelial Carcinoma. Jun 6, 2017 374
Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFR[eth] D842V Mutation. Jun 5, 2017 3266
New Precision Medicine Data on DS-8201 in HER2-Expressing Breast Cancer Revealed at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting. Jun 5, 2017 1574
Array BioPharma, Bristol-Myers Squibb Partner to Study Treatment Regimen for Metastatic Colorectal Cancer. Jun 5, 2017 355
Astellas and Seattle Genetics Announce Updated Enfortumab Vedotin Phase 1 Data in Metastatic Urothelial Cancer at 2017 ASCO Annual Meeting. Jun 5, 2017 1720
Novartis announces clinical collaboration with Bristol-Myers Squibb to evaluate potential treatments in metastatic colorectal cancer. Jun 5, 2017 1946
United States : First Presentation of Efficacy Data from CheckMate -204 Evaluating the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab) Demonstrates Anti-tumor Activity in Advanced Melanoma Patients with Brain Metastases. Jun 5, 2017 557
United States : Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrated Promising Activity in Previously Treated Patients with dMMR or MSI-H Metastatic Colorectal Cancer in Phase 2 CheckMate -142 Study. Jun 5, 2017 433
United States : Lynparza significantly reduces the risk of disease worsening or death in patients with BRCA-mutated metastatic breast cancer. Jun 5, 2017 520
How Can We Stop Cancer Cells From Spreading? Jun 5, 2017 575
Abiraterone Acetate Provided Significant Clinical Benefit in Patients with High-Risk Metastatic Hormone-NaE[macron]ve Prostate Cancer (mHNPC), Improving Overall Survival and Radiographic Progression-Free Survival. Jun 3, 2017 2922
Boston Biomedical Presents Data Suggesting Anti-Cancer Activity of Investigational Stemness Inhibitor Napabucasin in Seven Tumor Types at ASCO 2017. Jun 3, 2017 2448
ARMO BioSciences Announces Promising Response Rates and Survival Data in Patients with Advanced NSCLC and RCC from Phase 1/1b Trial for Immunotherapy AM0010 with Checkpoint Inhibitors. Jun 3, 2017 1591
Switzerland : Novartis presents updated data that reinforce the efficacy and safety of Kisqali (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer. Jun 3, 2017 350
Further Study of Combination of Eisai's Lenvatinib and Merck's Pembrolizumab in Previously Treated Patients with Metastatic Endometrial Cancer Supported by Interim Analysis of Ongoing Phase 1b/2 Trial. Jun 3, 2017 3389
Immunotherapy Drug Effective For Metastatic Triple Negative Breast Cancer. Jun 3, 2017 781
Novartis presents updated data that reinforce the efficacy and safety of Kisqali (ribociclib) plus letrozole as a first-line option for HR+/HER2- advanced or metastatic breast cancer. Jun 2, 2017 2599
Novartis provides updated data reinforcing efficacy and safety of Kisqali plus letrozole for HR+/HER2-advanced or metastatic breast cancer. Jun 2, 2017 304
Novartis provides updated data reinforcing efficacy and safety of Kisqali plus letrozole for HR+/HER2-advanced or metastatic breast cancer. Jun 2, 2017 300
Cancer. Jun 1, 2017 167
Multiple Polypoid Colonic Metastases from Primary Gastric Signet Ring Cell Carcinoma. Zhang, Lu-Yang; Ma, Jun-Jun; Zang, Lu; Dong, Feng; He, Zi-Rui; Zheng, Min-Hua Report Jun 1, 2017 1275
Osteros Biomedica Presents Results of a Phase 1 Study of MBC-11, a Bone-Targeting Conjugate in Cancer Patients with Bone Metastases at ASCO Annual Meeting 2017. Jun 1, 2017 439
New research in kidney cancer, ASCO-GU 2017. Basappa, Naveen; Pouliot, Frederic Jun 1, 2017 1491
Liver transplantation for non-resectable colorectal liver metastases at a single centre in South Africa: a report of the ethics and regulatory approval process. Etheredge, H.R.; Botha, J.; Cleaton-Jones, P. Report Jun 1, 2017 1775
Matrix metalloproteinases in urinary system tumours. Part I - Matrix metalloproteinases in renal cell carcinoma. Mlynarczyk, G.; Kudelski, J.; Darewicz, B.; Galewska, Z.; Romanowicz, L. Report Jun 1, 2017 4872
Matrix metalloproteinases in urinary system tumors. Part II - Matrix metalloproteinases in urinary bladder carcinoma. Mlynarczyk, G.; Kudelski, J.; Darewicz, B.; Galewska, Z.; Romanowicz, L. Report Jun 1, 2017 3666
Metilacion de genes supresores de tumores en pacientes venezolanos con leucemia linfoide aguda. Brito Acosta, Rutmelania; Rojas de Atencio, Alicia; Prieto, Carem; Gonzalez Ferrer, Sandra; Urdaneta Ensayo Jun 1, 2017 4961
Early vulvar and umbilical incisional scar recurrence of cervical squamous cell carcinoma: Earlier than usually expected/Skuamoz hucreli servikal karsinomun erken vulvar ve umbilikal insizyonel skar rekurrensi: Beklenilenden daha erken. Ozcan, Huseyin Caglayan; Mustafa, Aynur; Bozdag, Zehra; Sucu, Seyhun; Ugur, Mete Gurol; Balat, Ozcan Report Jun 1, 2017 2051
United States : Advaxis and Bristol-Myers Squibb Announce Clinical Collaboration to Evaluate ADXS-DUAL and Opdivo (nivolumab) in Metastatic Cervical Cancer. May 31, 2017 329
Lilly Announces Phase 3 RANGE Urothelial Cancer Trial of CYRAMZA (ramucirumab) Met Primary Endpoint, Improving Progression-Free Survival. Clinical report May 31, 2017 4616
Array BioPharma and Bristol-Myers Squibb Announce Strategic Collaboration. May 30, 2017 5424
Innovative Patient Registry to Provide Important Insights into the "Real World" Management of Metastatic Colorectal Cancer. Disease/Disorder overview May 30, 2017 739
FDA approves expanded use of Novartis drug Zykadia in first-line ALK-positive metastatic NSCLC. May 30, 2017 232
FDA approves expanded use of Novartis drug Zykadia in first-line ALK-positive metastatic NSCLC. May 30, 2017 228
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 278
Novartis wins US FDA approval to expand use of Zykadia for treating patients with metastatic non-small cell lung cancer. May 29, 2017 274
Switzerland : Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC). May 29, 2017 440
Novartis receives FDA approval for expanded use of Zykadia in first-line ALK-positive metastatic non-small cell lung cancer (NSCLC). May 26, 2017 2928
Experts Present New Radiosurgery Techniques Using Varian Technology for Optimal Targeting of Multiple Metastases. May 25, 2017 637
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. May 24, 2017 1095
Metastatic Colorectal Cancer Patients Treated First-line With SIR-Spheres Y-90 Resin Microspheres More Likely to Become Candidates for Potentially Curative Liver Surgery, REsect Study Shows. May 24, 2017 1101
United States : FDA approves first cancer treatment for any solid tumor with a specific genetic feature. May 24, 2017 835
Daiichi Sankyo Cancer Enterprise Pipeline Data Showing Swift Progress in Precision Medicine for Breast Cancer to be Presented at 2017 American Society of Clinical Oncology (ASCO) Annual Meeting. May 23, 2017 1562
Churchill Pharmaceuticals Announces Submission of NDA for Novel Oral Formulation of Prostate Cancer Treatment. Clinical report May 23, 2017 950
FDA approves first cancer treatment for any solid tumor with a specific genetic feature. May 23, 2017 971
Bone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.com. May 23, 2017 768
Bone Metastasis Therapeutic Pipeline Review H1 2017 Research Report Now Available at RnRMarketResearch.com. May 23, 2017 772
New Jersey Health Foundation Awards $50,000 Innovation Grant To Princeton University Researchers Studying Metastatic Cancer Cells. May 22, 2017 440
Eisai Data at ASCO 2017 Annual Meeting Showcase Latest Results of Ongoing Research in Oncology. May 18, 2017 3280
Shaping Cancer Care Today and Tomorrow: Merck to Present New Data from Rapidly Evolving Pipeline at ASCO 2017. May 17, 2017 2590
Merck KGaA, Darmstadt, Germany, and Pfizer to Present Data Highlighting Potential of Avelumab in Challenging Cancers at ASCO 2017. May 17, 2017 2692
Shaping Cancer Care Today and Tomorrow: Merck, KGaA, Darmstadt, Germany, to Present New Data from Rapidly Evolving Pipeline at ASCO 2017. May 17, 2017 2756
Oncolytics Biotech[R] Announces ASCO Abstracts and Preliminary Data for Studies in Pancreatic and Prostate Cancers. Clinical report May 17, 2017 1152
Next-Generation Cancer Diagnostics Market Forecast 2017-2027. May 16, 2017 814
Next-Generation Cancer Diagnostics Market Forecast 2017-2027. May 16, 2017 819
Dendreon Releases Results of New Proceed Registry Analysis Showing Overall Survival Benefit with Provenge in Metastatic Prostate Cancer. May 16, 2017 250
New Studies Demonstrate Impact of BRCA, DNA Repair Gene Mutations in Prostate Cancer. May 13, 2017 761
Oncotype DX Genomic Prostate Score(TM) (GPS) Test Predicts 10-year Risk of Prostate Cancer-specific Death and Metastases in Patients with Early-stage Disease. Clinical report May 12, 2017 1157
OncoSec Announces Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse IL-12 and KEYTRUDA (pembrolizumab) for Metastatic Melanoma. May 10, 2017 927
Pfizer Inc announces US FDA approval of BAVENCIO (avelumab) for Advanced Bladder Cancer; Its second approval in less than two months. May 10, 2017 285
Pfizer Inc announces US FDA approval of BAVENCIO (avelumab) for Advanced Bladder Cancer; Its second approval in less than two months. May 10, 2017 281
FDA Approves US Merck's Keytruda as First-Line Combination Therapy with Pemetrexed and Carboplatin for Patients with Metastatic Nonsquamous Non-Small Cell Lung Cancer, Irrespective of PD-L1 Expression. May 10, 2017 390
United States : FDA Grants BAVENCIO (avelumab) Approval for a Common Type of Advanced Bladder Cancer. May 10, 2017 666
FDA Grants BAVENCIO (avelumab) Approval for a Common Type of Advanced Bladder Cancer. May 9, 2017 4074
Novartis awarded US FDA approval for first-of-its-kind Kisqali Femara co-pack for initial treatment of advanced or metastatic breast cancer. May 9, 2017 330
Novartis awarded US FDA approval for first-of-its-kind Kisqali Femara co-pack for initial treatment of advanced or metastatic breast cancer. May 9, 2017 326
Array BioPharma partners with Merck to investigate metastatic colorectal cancer patients with microsatellite stable tumours. May 9, 2017 301
Oncolytics Biotech awarded US FDA Fast Track designation for REOLYSIN to treat metastatic breast cancer. May 9, 2017 233
Array BioPharma partners with Merck to investigate metastatic colorectal cancer patients with microsatellite stable tumours. May 9, 2017 297
Oncolytics Biotech awarded US FDA Fast Track designation for REOLYSIN to treat metastatic breast cancer. May 9, 2017 229
Oncolytics Biotech[R] Inc. Announces FDA Fast Track Designation for REOLYSIN[R] in Metastatic Breast Cancer. May 8, 2017 785
Array BioPharma Announces Strategic Collaboration with Merck. May 8, 2017 1055
Novartis receives FDA approval for first-of-its-kind Kisqali Femara Co-Pack for initial treatment of HR+/HER2- advanced or metastatic breast cancer. May 8, 2017 1989
META-DORM: Mechanobiology of METAstatic and DORMant cancer cells in bone marrow lesions. May 6, 2017 399
Japan : Takeda Announces FDA Accelerated Approval of ALUNBRIGTM (brigatinib). May 2, 2017 426
FDA approves first treatment for metastatic Merkel cell. Nikolaides, Laura May 1, 2017 341
Pigmented skin lesions lightened during immunotherapy. Smith, Jennie May 1, 2017 363
Cytoreductive nephrectomy in the modern era: Predictors of use, morbidity, and survival. Minnillo, Brian J.; Tabayoyong, William; Francis, John J.; Maurice, Matthew J.; Zhu, Hui; Kim, Simon Report May 1, 2017 5017
Sonomorphological, gray scale and color Doppler flow imaging evaluation of ovarian lesions. Diwanji, Nehal Sanket; Panchal, Minal; Sastri, Mona Report May 1, 2017 4030
A rare case of disseminated malignant melanoma. Sharma, Anuj; Shanker, Vinay; Tegta, Gita Ram; Verma, Ghanshyam Kumar; Rattan, Renu Case study May 1, 2017 1463
Comparative effect of Maitake Pro4x with Chemotherapy breast cancer treatment. Braico, Diego Aguilera; Roldan-Deamicis, Agustina; Brie, Belen; Balogh, Gabriela Andrea Report May 1, 2017 5426
Optimal Diagnostic Yield Achieved With On-site Pathology Evaluation of Fine-Needle Aspiration-Assisted Core Biopsies for Pediatric Osseous Lesions: A Single-Center Experience. Patel, Kalyani; Kinnear, Darryl; Quintanilla, Norma M.; Hicks, John; Castro, Eumenia; Curry, Choladd Report May 1, 2017 4698

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters